http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-4451-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1423c86b7c3e447dce2705e661f6d63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b21b83f813d071a321cd2e0ae215ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc30be4b138b188b43634a54b46a5d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6b9169d82fb5098e607b613bd656cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_671c3232b58207a8969c52940dfb8d80 |
| publicationDate | 2016-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MD-4451-B1 |
| titleOfInvention | A pharmaceutical composition containing nalbuphine hydrochloride, its use for the treatment of moderate to high intensity pain syndrome and a method for producing the pharmaceutical composition |
| abstract | The invention relates to the field of medicine and the chemical-pharmaceutical industry, more specifically to the creation, production and use of a medicament for the treatment (jugulation) of the medium and high intensity algal syndrome in different fields of medicine, in particular in oncology. use of nalbufin salt in the form of suppositories on a hydrophilic emulsion basis for the treatment of medium and high intensity algal syndrome. The pharmaceutical composition for the treatment of medium and high intensity algal syndrome in the form of suppositories contains as active substance nalbufin hydrochloride and a hydrophilic emulsion base. A process for obtaining a pharmaceutical composition, wherein the nalbufin hydrochloride is dissolved in propylene glycol, the solution is mixed with the molten hydrophilic emulsion base and homogenized; the liquid suppository mass is dosed in contour cell packs and cooled. |
| priorityDate | 2012-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.